High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa.

Autor: Inzaule SC; HIV/Hepatitis/STI Department, World Health Organization, Geneva, Switzerland., Jordan MR; Tufts University School of Medicine, Boston, USA., Bello G; Ministry of Health, Lilingwe, Malawi., Wadonda-Kabondo N; Centers for Disease Control & Prevention, Lilongwe, Malawi., Mounerou S; Faculty of Health Sciences, Molecular Biology Laboratory, University of Lomé, Lomé, Togo., Mbulli IA; Global Health Systems Solutions, Douala, Cameroon., Akanmu SA; Department of Haematology and Blood Transfusion, Lagos University Teaching Hospital, and College of Medicine of the University of Lagos, Lagos, Nigeria., Vubil A; Instituto Nacional de Saúde, Maputo, Mozambique., Hunt G; National Institute for Communicable Diseases, Johannesburg, South Africa., Kaleebu P; Uganda Virus Research Institute, Entebbe, Uganda., Mthethwa-Hleza S; Ministry of Health Eswatini, Mbabane, Eswatini., Dzangare J; Ministry of Health and Child Care, Harare, Zimbabwe., Njukeng P; Global Health Systems Solutions, Douala, Cameroon., Penazzato M; HIV/Hepatitis/STI Department, World Health Organization, Geneva, Switzerland., Rinke de Wit TF; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, The Netherlands., Eshleman SH; Johns Hopkins University. School of Medicine, Baltimore, Maryland, USA., Bertagnolio S; HIV/Hepatitis/STI Department, World Health Organization, Geneva, Switzerland.

Publikováno v: AIDS (London, England) [AIDS] 2020 Aug 01; Vol. 34 (10), pp. 1567-1570.